Albumedix extends research collaboration with Cobra Biologics to optimize viral vector manufacturing
News provided by
Share this article
Share this article
Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers
NOTTINGHAM, United Kingdom and KEELE, United Kingdom, April 28, 2021 /PRNewswire/ Albumedix Ltd. ( Albumedix ), an emerging leader in the enablement of advanced therapies and recognized global leader in recombinant human albumin (rHA) has today announced an extension to its research collaboration with Cobra Biologics, the gene therapy division of Cognate BioServices, a Charles River Laboratories International, Inc. company. The research collaboration focuses on process optimization and stability enhancement in scale-up manufacturing of AAV and lentiviral vectors through Albumedix proprietary recombinant human albumin-based product.
Global Viral Clearance Market Statistics with Top 10 Key players in 2021 |Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc (US), and Texcell Inc (France), Kedrion (Italy) – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
GMP Cell Banking Market Research Methods that Will Give You Proven Results | Forecast 2021-2027 | WuXi AppTec, Charles River Laboratories International, Inc , Eurofins Scientific, Merck KGaA, Lonza Group Ltd, SGS Ltd, ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc , Paragon Bioservices, and Inc – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Contract Research Organizations
Want to know what all technological upgradations lay in the Rapid Microbial Detection Systems market? Have a look at the “Table of Content” of Rapid Microbial Detection Systems market report! https://www.persistencemarketresearch.com/toc/15703
Rapid Microbial Detection Systems Market: Overview
Rapid microbial detection system market is expected to show significant growth over the forecast period. This system is faster and more precise than the traditional microbial detection system. Also in traditional detection method higher colony growth is required as process is done by vision detection but rapid microbial detection system can detect and identify microbial growth even in case of lower culture growth. Adenosine triphosphate bioluminescence technique is most used as this technique is considered as gold standard in the microbial detection system and it is more precise for detection. Rapid microbial detection system are automated system which